An experimental drug nearly doubled the overall survival rates of pancreatic cancer patients, accord...
Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial
An experimental drug nearly doubled the overall survival rates of pancreatic cancer patients, according to the results of its latest clinical trial.
Author: USA Today
Read Original Article